Tag Archives: Most

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

Professor Larry Corey, principal researcher of the AMP studies, speaking at HIVR4P Two years ago, at the HIV Research for Prevention (HIVR4P) conference in Madrid, Professor Lynn Morris of the South African National Institute for Communicable Diseases made a prediction about the AMP (Antibody-Mediated Protection) studies. The two studies are the first large studies using injections every… Read More »

Most Americans probably won’t be able to get a Covid-19 vaccine until mid-2021, CDC director says

“Those who are vaccine hesitant have had their hesitancy enhanced by a variety of things that are happening right now, particularly the unfortunate mix of science and politics,” Collins said at an event hosted by the National Academies of Sciences, Engineering and Medicine. A recent poll from the Kaiser Family Foundation found that more than… Read More »